Information Provided By:
Fly News Breaks for March 7, 2016
MD
Mar 7, 2016 | 07:42 EDT
As reported previously, Susquehanna downgraded MEDNAX to Neutral from Positive as M&A related EBITDA growth headwinds, plus slowing core growth, may make the consensus earnings estimates for the second half of 2016 unachievable. Susquehanna lowered its price target to $70 from $94 on MEDNAX shares.
News For MD From the Last 2 Days
There are no results for your query MD